Sober Up, Buttercup: Why Quantum BioPharma’s Alcohol Detox Drink ‘unbuzzd’ is a Game-Changer
Backed by a team of heavy hitters, including the former Celsius Holdings CEO, ex-Coca-Cola VP, and an original Shark Tank investor, unbuzzd is poised to shake up the multibillion-dollar functional beverage market.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is redefining how we recover from alcohol consumption with its revolutionary product, unbuzzd™. Touted as a game-changer in the functional beverage market, unbuzzd is scientifically designed to accelerate alcohol metabolism, offering relief from inebriation while promoting mental clarity. With the backing of industry heavyweights and a unique formula, unbuzzd is poised to disrupt a multibillion-dollar industry.
A Visionary Backing
Kevin Harrington, an original investor on the hit show Shark Tank, inventor of the infomercial, pioneer of the “As Seen on TV” brand, and Quantum BioPharma advisor, is one of the prominent supporters of unbuzzd. Having launched over 1,000 products worldwide, generating over $6 billion in global sales, Harrington is confident in unbuzzd’s potential.
Highlighting the product’s ability to restore mental clarity and support responsible alcohol consumption, Harrington stated:
“It’s a revolution in how we recover from alcohol.”
Harrington, who believes that unbuzzd is more than just a hangover cure, added:
“This is going to change society.”
Gerry David, former CEO of Celsius Holdings (NASDAQ: CELH) and Quantum BioPharma advisor, shares Harrington’s optimism, stating:
“I have seen countless products throughout my career and I can honestly say that I have never seen anything as unique and disruptive as the product Quantum BioPharma is developing to counteract alcohol intoxication and misuse.”
Source: Quantum BioPharma YouTube
The Science Behind unbuzzd
Unlike traditional hangover remedies, unbuzzd is a proactive solution designed to optimize alcohol metabolism and alleviate common symptoms such as dehydration, brain fog, and sluggishness. The formula boasts a blend of natural ingredients, including green tea extract, phenylalanine, milk thistle, dihydromyricetin (DHM), and methylliberine. These ingredients work synergistically to hydrate, detoxify, and boost cognitive function within 30 minutes of consumption.
Green tea extract provides antioxidants to combat oxidative stress, while milk thistle aids liver repair. Phenylalanine supports neurotransmitter production, improving mood and reducing fatigue. DHM accelerates alcohol metabolism and offers liver protection, and methylliberine enhances energy and mental focus. Together, these elements form the backbone of unbuzzd’s efficacy.


Track Record of Success
The team behind unbuzzd includes industry veterans who have previously transformed the functional beverage market. Gerry David’s leadership at Celsius Holdings turned the company into a global powerhouse, delivering a 35-fold increase in market capitalization.
Over the past 10 years, Celsius Holdings was one of the top-performing stocks in the entire market. From a low of $0.10 in 2014 to its recent 52-week high of $99.62, Celsius Holdings generated a 10-year return on investment of 99,520%.
The playbook that propelled Celsius to its massive success is now being applied to unbuzzd, with Gerry David and Kevin Harrington leveraging their expertise to position the product as a category-defining innovation.
Quantum BioPharma’s strategic decision to spin off unbuzzd under Celly Nutrition further underscores its commitment to market expansion. Retaining a 25.71% stake in the company, Quantum BioPharma aims to establish unbuzzd as a staple in vacation destinations and everyday life, offering relief to consumers and addressing the broader societal impact of alcohol consumption.
unbuzzd Hits the Shelves
unbuzzd is currently available in “Clear-Eyed Citrus” flavor in convenient grab-and-go stick packs and will soon launch as a ready-to-drink 12-ounce can. Consumers can purchase the product on Amazon (NASDAQ: AMZN) or directly from the company’s website, aligning with the growing trend toward e-commerce and convenience. Celly Nutrition’s strategic partnership with FUSION Consulting Group ensures that unbuzzd will also reach major retailers such as Walmart (NYSE: WMT), Walgreens (NASDAQ: WBA), CVS (NYSE: CVS), and Costco (NASDAQ: COST).


Tapping Into a Booming Market
The US functional beverage market is experiencing unprecedented growth, driven by rising demand for health-conscious products. In 2023, the global detox drinks market was valued at $5.36 billion and is projected to nearly double by 2032, reaching $9.66 billion. Quantum BioPharma’s unbuzzd is well-positioned to capitalize on this momentum, offering a solution tailored to modern consumers who prioritize wellness.
John Duffy, CEO of Celly Nutrition and former VP of Sales at Coca-Cola (NYSE: KO), emphasized unbuzzd’s potential while highlighting its role in bridging social enjoyment and next-day productivity, stating:
“Why are alcohol drinkers reaching for recovery drinks? Because life goes on after cocktails.”
Investor Interest and Industry Implications
unbuzzd’s potential to disrupt the beverage industry has drawn comparisons to early-stage success stories like Celsius and Monster Beverage (NASDAQ: MNST). Both companies leveraged innovative formulations to dominate new market segments, creating significant shareholder value. Quantum BioPharma’s vision for unbuzzd positions it as a contender to follow in their footsteps.
As unbuzzd gains traction, it could redefine consumer expectations for functional beverages. With its ability to address immediate recovery needs and long-term wellness goals, the product appeals to a diverse demographic, from fitness enthusiasts to busy professionals.
A New Chapter in Wellness
unbuzzd represents more than a product; it’s a movement toward responsible enjoyment and recovery.
As Gerry David aptly put it:
“[unbuzzed is] truly a product that will affect so many lives in such a positive way. I look forward to helping make unbuzzd™ a mainstream success.”
Backed by science, innovation, and a team of seasoned professionals, unbuzzd is poised to make waves in 2024 and beyond.
With its launch, Quantum BioPharma joins the ranks of industry leaders, solidifying its reputation as a trailblazer in the functional beverage space. As unbuzzd hits the shelves of major retailers and e-commerce platforms, it’s clear that this is just the beginning of a promising journey for Quantum BioPharma and its groundbreaking product.
Read Next: Why This Small Biotech Stock Could Be Primed for a Breakout
Join the Discussion in the WVC Facebook Investor Group
Do you have a stock tip or news story suggestion? Please email us at Invest@WealthyVC.com.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.
Wealthy VC and its employees are not Registered Investment Advisors, Broker-Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Wealthy VC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Wealthy VC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Our website and newsletter are for entertainment purposes only. This website is NOT a source of unbiased information. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
Release of Liability: Through the use of this email and/or website advertisement, by viewing or using it, you agree to hold Wealthy VC, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Wealthy VC-sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by Wealthy VC or an offer or solicitation to buy or sell any security. WealthyVC and our controlling entity 1000724287 Ontario Ltd have been compensated USD $20,000 for social media marketing and USD $7,500 per month for 3 months for investor relations by Quantum BioPharma Ltd.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Wealthy VC strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D and all reports published on SEDAR if the company featured is Canadian. Wealthy VC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors with a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements”. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day’s closing price and the high of-day price during our promotional coverage.
In preparing this publication, Wealthy VC has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, Wealthy VC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Wealthy VC is not responsible for any claims made by the companies advertised herein, nor is Wealthy VC responsible for any other promotional firm, its program or its structure.